Short Interest in Genfit S.A. (OTCMKTS:GNFTF) Expands By 40.0%

Genfit S.A. (OTCMKTS:GNFTFGet Rating) saw a significant growth in short interest in February. As of February 28th, there was short interest totalling 700 shares, a growth of 40.0% from the February 13th total of 500 shares. Based on an average trading volume of 100 shares, the short-interest ratio is presently 7.0 days.

Genfit Stock Performance

Shares of OTCMKTS:GNFTF opened at $4.39 on Tuesday. Genfit has a 52-week low of $3.13 and a 52-week high of $4.39. The firm has a fifty day moving average of $3.84 and a 200 day moving average of $3.76.

About Genfit

(Get Rating)

Genfit SA is a biopharmaceutical company involved in drug discovery and development for the early diagnosis, prevention and treatment of cardiometabolic diseases. The company focuses on the discovery and development of drug candidates in areas of high unmet medical needs corresponding to a lack of suitable treatments.

See Also

Receive News & Ratings for Genfit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genfit and related companies with MarketBeat.com's FREE daily email newsletter.